The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression
Authors:
- 27 March 2013
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 27 (7) , 575-583
Abstract
Background: Symptoms of cognitive impairment such as poor concentration, memory loss and difficulty with decision making are prevalent in patients with depression, but currently are not specific targets for treatment. However, patients can continue to demonstrate cognitive impairments even when apparently clinically recovered. Drugs that potentiate serotonin (5-HT) function, such as selective serotonin reuptake inhibitors (SSRIs), are the mainstay of treatment for depression. Nevertheless, our understanding of the effects of SSRIs and other conventional antidepressant therapy on cognitive function in healthy humans and depressed patients remains limited. Objective: The purpose of this article is to provide a concise overview for clinicians on the impact of pharmacological manipulation of 5-HT on cognitive function in healthy humans with additional reference to animal models where human data are lacking, particularly regarding specific 5-HT receptor subtype modulation. Findings: The most consistent observation following manipulation of serotonin levels in humans is that low extracellular 5-HT levels are associated with impaired memory consolidation. Preclinical data show that agonism and antagonism at specific 5-HT receptors can exert effects in animal models of cognition. Conclusions: Larger, consistently designed studies are needed to understand the roles of 5-HT in cognition in healthy and depressed individuals. Efforts to target specific 5-HT receptors to improve cognitive outcomes are warranted.Keywords
This publication has 88 references indexed in Scilit:
- Serotonin and Prefrontal Cortex Function: Neurons, Networks, and CircuitsMolecular Neurobiology, 2011
- Central nervous system effects of the interaction between risperidone (single dose) and the 5‐HT6antagonist SB742457 (repeated doses) in healthy menBritish Journal of Clinical Pharmacology, 2011
- Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant MedicationJournal of Clinical Psychopharmacology, 2011
- Neuropsychological Clustering Highlights Cognitive Differences In Young People Presenting With Depressive SymptomsJournal of the International Neuropsychological Society, 2011
- The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophreniaBMC Psychiatry, 2010
- A Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Young People at Increased Familial Risk of DepressionBiological Psychiatry, 2010
- A meta-analysis of depression severity and cognitive functionJournal of Affective Disorders, 2009
- Drug development for Alzheimer's disease: Where are we now and where are we headed?The American Journal of Geriatric Pharmacotherapy, 2009
- Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary studyBMC Psychiatry, 2007
- Depression and Risk for Alzheimer DiseaseArchives of General Psychiatry, 2006